Randomized control trial examines whether inhaled nitric oxide improves outcomes in extremely premature infants, suggesting potential benefits.
QUESTIONDoes inhaled nitric oxide (iNO) treatment for early echocardiographic pulmonary hypertension (PH) decrease the risk of death or bronchopulmonary dysplasia (BPD) in extremely preterm infants? METHODS DesignSingle-center double-blinded randomized control trial (RCT). PatientsInfants born less than or equal to 29 weeks' gestation who received positive pressure ventilation at 72 24 postnatal hours were eligible.
No takes yet. Share an insight, caveat, or question.
King et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: